Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „trial“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · Injection site reactions During the double-blind, controlled phases of the two long-term trials, injection sit
Eintrag öffnenAbilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and in post-marketing data both increase and decreas
Eintrag öffnenAbilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify Maintena · 4.8 · The most frequently observed ADRs reported in ≥ 5 % of patients in two double-blind, long-term trial of Abilif
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · a: Reported as very common in Abilify Maintena 960 mg/720 mg clinical trials. b: Reported only in Abilify Main
Eintrag öffnenAbilify · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAbilify · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAbilify · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP3A4
Eintrag öffnenAbilify · 4.5 · Ketoconazole and other CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a stron
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a strong i
Eintrag öffnenAbilify · 4.8 · 51 Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnen